Westin Wolfenden's Contact Details

Westin Wolfenden's Company Details

Princeton Identity

Trenton, NJ, US • 20 - 49 Employees
Technology Consulting/Tech Services

Princeton Identity is biometric identity management that makes security more accurate, reliable and convenient than ever before. Using iris recognition and other biometric technology, PI enables businesses, global organizations and borders to simplify identity management, resulting in improved safety and protection.Our software and physical hardware provide versatile identity authentication solutions designed to verify and manage individuals' identities for a wide range of physical security and access applications. With proven installations around the world, Princeton Identity offers system solutions for a diverse range of mainstream applications, including mobile access control, corporate, industrial and secure workplaces, as well as airports, critical infrastructure, public arenas, and border control.Princeton Identity creates products for organizations seeking new ways to streamline security, increase throughput, optimize operations, and control costs. Our solutions deliver high-accuracy minimal user interaction—ideal for authentication in markets such as security, transportation, airports, finance, healthcare, and others. The company's unique multimodal biometric solutions employ distinctive iris and facial recognition technologies designed for accuracy and ease of use.Princeton Identity Inc. was formerly a division of SRI International marketed under the SRI Identity brand. SRI and SRI Identity have had a long and successful history of delivering leading-edge technology, going back to the roots of the company in Stanford University, RCA Labs, and Sarnoff Labs, where many familiar technologies were born. Some of these technologies have become household items, including color television, the computer mouse, and Siri (purchased by Apple). Others have had broader impact, such as ground-scanning satellites, automated check processing, medical devices, and cancer-fighting drugs.